Cindy L. O'Bryant, PharmD, BCOP, FCCP, FHOPA

This activity is supported by an educational grant from Merck Sharpe & Dohme Corp.

Understanding the Evolving Landscape of Malignant Melanoma

Cindy L. O’Bryant, PharmD, BCOP, FCCP, FHOPA

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

University of Colorado Anschutz Medical Campus

After completing this continuing education program, the participant will be able to:

Explore medical management of patients with malignant melanoma based on risk factors, presentation, assessment, and diagnosis parameters.

Discover current and emerging treatment options for malignant melanoma.

Employ the role of the pharmacist in supporting optimal treatment strategies in malignant melanoma management.

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-047-H01-P. The activity is available for CE credit through May 16, 2018.

Articles

This Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.